|
Market Closed -
Other stock markets
|
After hours 05:59:55 am | |||
| 22.66 EUR | -0.13% |
|
22.52 | -0.62% |
| 01:06am | Where would AI lead Pharma in the long run? |  |
| 14/07 | European Equities Mixed in Monday Trading; Eni to Fuel BMW Corporate Fleets With Renewable Diesel | MT |
| Market Cap | 76.5B 103B 89.58B 82.81B 144B 9,846B 147B 988B 387B 4,821B 385B 377B 16,600B | P/E 2026 * |
12.2x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 91.79B 123B 107B 99.35B 173B 11,813B 176B 1,185B 465B 5,784B 462B 452B 19,917B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.49x |
| Free-Float |
92.29% | Yield 2026 * |
3.63% | Yield 2027 * | 3.82% |
Last Transcript: GSK plc
| 01:06am | Where would AI lead Pharma in the long run? | |
| 13/07 | GSK : UBS remains Neutral | ZD |
| 13/07 | GSK : JP Morgan remains a Sell rating | ZD |
| 09/07 | GSK : Deutsche Bank remains Neutral | ZD |
| 09/07 | Computacenter gets two price target hikes | AN |
| 1 day | -0.75% | ||
| 1 week | -2.41% | ||
| Current month | -2.03% | ||
| 1 month | -1.13% | ||
| 3 months | -9.36% | ||
| 6 months | +6.29% | ||
| Current year | +7.90% |
| 1 week | 22.66 |  | 23.26 |
| 1 month | 22 | | 23.7 |
| Current year | 20.27 | | 26.02 |
| 1 year | 15.35 | | 26.02 |
| 3 years | 14.68 | | 26.02 |
| 5 years | 14.62 | | 27.13 |
| 10 years | 14.62 | | 27.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -2.41% | - | - | 104B | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,054B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 621B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 438B | |
| -1.12% | -1.45% | +27.34% | +22.20% | 325B | |
| -1.73% | -2.14% | +27.22% | +44.70% | 281B | |
| -1.95% | -12.31% | +18.32% | +19.69% | 262B | |
| -1.45% | -0.44% | -27.17% | -38.86% | 219B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 195B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 163B | |
| Average | -1.45% | -1.70% | +23.91% | +51.95% | 395.13B | |
| Weighted average by Cap. | -1.47% | -1.69% | +33.44% | +77.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.88B 45.4B 39.67B 36.67B 63.81B 4,361B 64.96B 437B 172B 2,135B 171B 167B 7,352B | 35.63B 47.73B 41.71B 38.56B 67.09B 4,585B 68.3B 460B 180B 2,245B 179B 175B 7,730B |
| Net income | 6.52B 8.74B 7.64B 7.06B 12.28B 839B 12.51B 84.2B 33.03B 411B 32.83B 32.1B 1,415B | 7.04B 9.44B 8.25B 7.62B 13.27B 907B 13.51B 90.93B 35.68B 444B 35.45B 34.67B 1,529B |
| Net Debt | 15.29B 20.48B 17.9B 16.55B 28.79B 1,967B 29.31B 197B 77.42B 963B 76.93B 75.23B 3,317B | 12.22B 16.38B 14.31B 13.23B 23.02B 1,573B 23.44B 158B 61.9B 770B 61.52B 60.16B 2,652B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | EUR 22.66 | -0.13% | 0 |
| 13/07/26 | EUR 22.69 | -1.05% | 232 |
| 10/07/26 | EUR 22.93 | +0.84% | 250 |
| 09/07/26 | EUR 22.74 | -0.61% | 525 |
| 08/07/26 | EUR 22.88 | -1.34% | 220 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
